GB1441747A - Veterinary compositions - Google Patents

Veterinary compositions

Info

Publication number
GB1441747A
GB1441747A GB4801772A GB4801772A GB1441747A GB 1441747 A GB1441747 A GB 1441747A GB 4801772 A GB4801772 A GB 4801772A GB 4801772 A GB4801772 A GB 4801772A GB 1441747 A GB1441747 A GB 1441747A
Authority
GB
United Kingdom
Prior art keywords
composition
oct
heavy metal
metal salt
veterinary compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4801772A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAZONBY B
Original Assignee
LAZONBY B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAZONBY B filed Critical LAZONBY B
Priority to GB4801772A priority Critical patent/GB1441747A/en
Publication of GB1441747A publication Critical patent/GB1441747A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof

Abstract

1441747 Veterinary composition B LAZONBY 16 Oct 1973 [18 Oct 1972] 48017/72 Heading A5B A veterinary composition comprises (a) an antibiotic or other antibacterial agent and (b) a non-toxic heavy metal salt both contained in a solid or semi-solid base which melts at a temperature at or below bovine body temperature. The heavy metal salt may be a basic bismuth salt. The composition may be used in a dosage unit form containing 5 to 15 gms. of said composition.
GB4801772A 1972-10-18 1972-10-18 Veterinary compositions Expired GB1441747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4801772A GB1441747A (en) 1972-10-18 1972-10-18 Veterinary compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4801772A GB1441747A (en) 1972-10-18 1972-10-18 Veterinary compositions

Publications (1)

Publication Number Publication Date
GB1441747A true GB1441747A (en) 1976-07-07

Family

ID=10447071

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4801772A Expired GB1441747A (en) 1972-10-18 1972-10-18 Veterinary compositions

Country Status (1)

Country Link
GB (1) GB1441747A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2273441A (en) * 1992-12-08 1994-06-22 Bimeda Res Dev Ltd Veterinary composition for treating mastitis
US6254881B1 (en) * 1996-12-18 2001-07-03 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
WO2005051352A1 (en) 2002-12-20 2005-06-09 Pfizer Limited Veterinary compositions for treating mastitis
US7828765B2 (en) 2004-02-02 2010-11-09 Bimeda Research & Development Ltd Method and device for administering two components into the teat canal of a non-human animal
EP2344168A1 (en) 2008-09-17 2011-07-20 Mastitis Research Centre Limited Anti-infective formulation and methods of use
US8795714B2 (en) 2006-10-10 2014-08-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
AU2013202381B2 (en) * 2006-10-10 2016-05-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US9694134B2 (en) 2013-09-16 2017-07-04 Zoetis Services Llc Assembly for sequentially delivering substances, and associated methods
US9956167B2 (en) 2009-04-08 2018-05-01 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
WO2020229851A3 (en) * 2019-05-15 2021-02-11 Aristotle University Of Thessaloniki - E.L.K.E. Edible veterinary intramammary teat sealant formulations and method for their preparation

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2273441A (en) * 1992-12-08 1994-06-22 Bimeda Res Dev Ltd Veterinary composition for treating mastitis
WO1994013261A1 (en) * 1992-12-08 1994-06-23 Bimeda Research And Development Limited Aqueous antibiotic composition for veterinary use
GB2273655A (en) * 1992-12-08 1994-06-29 Bimeda Res Dev Ltd Veterinary compositions for treating mastitis
GB2273655B (en) * 1992-12-08 1997-01-08 Bimeda Res Dev Ltd Veterinary compositions for the treatment of mastitis
GB2273441B (en) * 1992-12-08 1997-01-08 Bimeda Res Dev Ltd Veterinary compositions for treating mastitis
US8758831B2 (en) 1996-12-18 2014-06-24 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
US6506400B1 (en) 1996-12-18 2003-01-14 Bimeda Research & Development Ltd Antiinfective free intramammary veterinary composition
US6254881B1 (en) * 1996-12-18 2001-07-03 Bimeda Research & Development Limited Antiinfective free intramammary veterinary composition
US6340469B1 (en) 1996-12-18 2002-01-22 Bimeda Research And Development Ltd System for prophylactic treatment of mammary disorders
WO2005051352A1 (en) 2002-12-20 2005-06-09 Pfizer Limited Veterinary compositions for treating mastitis
EP1581184B2 (en) 2002-12-20 2020-09-09 Zoetis UK Limited Veterinary compositions for treating mastitis
US7828765B2 (en) 2004-02-02 2010-11-09 Bimeda Research & Development Ltd Method and device for administering two components into the teat canal of a non-human animal
US8353877B2 (en) 2004-02-02 2013-01-15 Bimeda Research & Development Limited Method for administering two components into the teat canal of a non-human animal
AU2013202381B2 (en) * 2006-10-10 2016-05-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US11491185B2 (en) 2006-10-10 2022-11-08 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US8795714B2 (en) 2006-10-10 2014-08-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
EP2893932A1 (en) 2008-09-17 2015-07-15 Bayer New Zealand Limited Anti-infective formulation and methods of use
AU2009304000B2 (en) * 2008-09-17 2015-08-06 Elanco New Zealand Anti-infective formulation and methods of use
AU2009304000C1 (en) * 2008-09-17 2022-04-28 Elanco New Zealand Anti-infective formulation and methods of use
EP2344168A1 (en) 2008-09-17 2011-07-20 Mastitis Research Centre Limited Anti-infective formulation and methods of use
US9956167B2 (en) 2009-04-08 2018-05-01 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US10744085B2 (en) 2009-04-08 2020-08-18 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
US9694134B2 (en) 2013-09-16 2017-07-04 Zoetis Services Llc Assembly for sequentially delivering substances, and associated methods
WO2020229851A3 (en) * 2019-05-15 2021-02-11 Aristotle University Of Thessaloniki - E.L.K.E. Edible veterinary intramammary teat sealant formulations and method for their preparation

Similar Documents

Publication Publication Date Title
CA993659A (en) Agent for desulphurising metal melts
ZA711189B (en) 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
ZA792656B (en) Rust-inhibiting agent for aqueous systems and rust-inhibiting lubricating composition
GB1441747A (en) Veterinary compositions
PH9682A (en) 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same
IL37492A (en) 6h-oxazolo(or thiazolo)(5,4-d)-azepine derivatives,their salts,preparation thereof and pharmaceutical compositions containing them
IL36398A0 (en) 3,4-dihydroisoquinoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
JPS5386038A (en) Pharmaceutical composition for animal and application
IL37280A0 (en) New adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL61210A0 (en) 3-benzoyl-2-nitrophenylacetic acids and metal salts, amides and esters thereof and pharmaceutical compositions containing them
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
IL42384A0 (en) N-benzhydryl-n'-p-hydroxybenzyl-piperazines and processes for their manufacture and pharmaceutical compositions containing them
CA984603A (en) Corrosion inhibiting composition and use thereof
GB1508601A (en) Oxytetracycline solution
IL41677A0 (en) Naphtholsulphonic acid derivatives and fungicidal compositions containing them
IL34086A (en) 1-aryl-1,2,3-triazole-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
GB1233150A (en)
CA971103A (en) Nematocidal and fungicidal compositions containing 2-halogeno-5-amino-1,3,4-thiadiazoles and salts thereof
IL37702A (en) Boric acid complexes of optionally n-substituted dopamine compounds,the corresponding n-substituted dopamine compounds and pharmaceutical compositions containing the latter
NZ187086A (en) 7-(halophenylmalonamido)-7a-methoxy-3-(optionally alkylated tetrazol-5-yl or 1,3,4-thiadiazol-2-yl)-thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
GB1287433A (en) Pharmaceutical compositions
ZA711188B (en) 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents
IT8121200A0 (en) DIPYRIDAMOLE ESTER, ANTI-PLATELET AGGREGATION SUITABILITY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID ESTER.
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee